level-one heading

Kolabtreeを選ぶ理由
開始はすばやく簡単です。初期費用はかかりません。
サービス依頼と専門家への見積依頼は無料です。
Kolabtree の作業範囲に同意する前に、専門家と要件を詳しく相談できます。
専門家と直接連携し、必要な成果を正しく得られます。
専門家を採用したらプロジェクトに資金を入れ、作業完了後に成果物を承認できます。
この専門家をプロジェクトに採用したいですか? 見積もりを依頼 無料で。
プロフィール詳細
プロジェクトを作成
★★★★★
☆☆☆☆☆
Hamed M.に依頼
United Kingdom

Expert Researcher in Antimicrobial Resistance and Bacterial Gene Regulation

プロフィール概要
専門分野
サービス
Research Feasibility Study, Scientific and Technical Research, Systematic Literature Review
Consulting Scientific and Technical Consulting
職務経験

Research Associate

Newcastle University

10月 2019 - 現在

Research Assistant

Newcastle University

4月 2012 - 2月 2015

学歴

PhD (Medical sciences)

Newcastle University

5月 2015 - 9月 2019

Master of Scicence (MSc) (School of Biology)

Newcastle University

9月 2010 - 9月 2011

Bachelor of Science (BSc) (Biology )

Islamic Azad University of Arsanjan

9月 2006 - 5月 2010

認定資格
  • 認定資格の詳細は未入力です。
出版物
JOURNAL ARTICLE
John Harbottle and Hamed Mosaei and Nicholas Allenby and Nikolay Zenkin(2021). Kanglemycin A can overcome rifamycin resistance caused by ADP-ribosylation by Arr protein . Antimicrobial Agents and Chemotherapy. American Society for Microbiology
Hamed Mosaei and Nikolay Zenkin(2021). Two distinct pathways of RNA polymerase backtracking determine the requirement for the Trigger Loop during RNA hydrolysis . Nucleic Acids Research. 49. (15). Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 8777--8784. Oxford University Press ({OUP})
Viralkumar V. Panchal and Caitlin Griffiths and Hamed Mosaei and Bohdan Bilyk and Joshua A. F. Sutton and Oliver T. Carnell and David P. Hornby and Jeffrey Green and Jamie K. Hobbs and William L. Kelley and Nikolay Zenkin and Simon J. Foster(2020). Evolving MRSA: High-level β-lactam resistance in Staphylococcus aureus is associated with RNA Polymerase alterations and fine tuning of gene expression . PLOS Pathogens. 16. (7). Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString e1008672. Public Library of Science ({PLoS})
Hamed Mosaei and Nikolay Zenkin(2020). Inhibition of RNA Polymerase by Rifampicin and Rifamycin-Like Molecules . EcoSal Plus. 9. (1). American Society for Microbiology
Hamed Mosaei and John Harbottle(2019). Mechanisms of antibiotics inhibiting bacterial RNA polymerase . Biochemical Society Transactions. 47. (1). Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 339--350. Portland Press Ltd.
Hamed Mosaei and Vadim Molodtsov and Bernhard Kepplinger and John Harbottle and Christopher William Moon and Rose Elizabeth Jeeves and Lucia Ceccaroni and Yeonoh Shin and Stephanie Morton-Laing and Emma Claire Louise Marrs and Corinne Wills and William Clegg and Yulia Yuzenkova and John David Perry and Joanna Bacon and Jeff Errington and Nicholas Edward Ellis Allenby and Michael John Hall and Katsuhiko S. Murakami and Nikolay Zenkin(2018). Mode of Action of Kanglemycin A, an Ansamycin Natural Product that Is Active against Rifampicin-Resistant Mycobacterium tuberculosis . Molecular Cell. 72. (2). Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 263--274.e5. Elsevier {BV}
Andrew R. Tyler and Hamed Mosaei and Stephanie Morton and Paul G. Waddell and Corinne Wills and William McFarlane and Joe Gray and Michael Goodfellow and Jeff Errington and Nick Allenby and Nikolay Zenkin and Michael J. Hall(2017). Structural Reassignment and Absolute Stereochemistry of Madurastatin C1 (MBJ-0034) and the Related Aziridine Siderophores: Madurastatins A1, B1, and MBJ-0035 . Journal of Natural Products. 80. (5). Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 1558--1562. American Chemical Society ({ACS})
Andrew R. Tyler and Hamed Mosaei and Stephanie Morton and Paul G. Waddell and Corinne Wills and William McFarlane and Joe Gray and Michael Goodfellow and Jeff Errington and Nick Allenby and Nikolay Zenkin and Michael J. Hall(2017). Structural Reassignment and Absolute Stereochemistry of Madurastatin C1 (MBJ-0034) and the Related Aziridine Siderophores: Madurastatins A1, B1, and MBJ-0035 . Journal of Natural Products. 80. (5). Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 1558--1562. American Chemical Society ({ACS})
PATENT
(2020). Compounds for Treating Infections Caused by Rifampicin-Resistant Bacteria.